RP11-592B15.4 Inhibitors
The chemical class denoted as RP11-592B15.4 Inhibitors comprises a group of compounds meticulously designed to selectively target the molecular entity RP11-592B15.4. This specific non-coding RNA, transcribed from the RP11-592B15.4 gene locus, is an intriguing area of focus within the realm of molecular biology. Despite the significant strides made in genomics, the functional roles and cellular processes associated with RP11-592B15.4 remain largely uncharacterized, warranting comprehensive investigations into its molecular interactions. Inhibitors within the RP11-592B15.4 Inhibitors class represent intricately engineered molecules with the primary goal of modulating the activity or function of RP11-592B15.4, thereby inducing an inhibitory effect. Researchers in this field employ a multifaceted approach, integrating insights from structural biology, medicinal chemistry, and computational modeling to unravel the intricate molecular interactions between the inhibitors and the target RP11-592B15.4.
Structurally, RP11-592B15.4 Inhibitors are characterized by specific molecular features designed to facilitate selective binding to RP11-592B15.4. This selectivity is paramount to minimize unintended effects on other cellular components, ensuring a focused impact on the intended molecular target. The development of inhibitors within this chemical class involves a comprehensive exploration of structure-activity relationships, optimization of pharmacokinetic properties, and a deep understanding of the molecular mechanisms associated with RP11-592B15.4. As researchers delve deeper into the functional aspects of RP11-592B15.4 Inhibitors, the knowledge generated contributes not only to deciphering the specific roles of RP11-592B15.4 but also to advancing our broader comprehension of non-coding RNA's involvement in cellular processes and molecular regulation. The exploration of RP11-592B15.4 Inhibitors represents a significant avenue for expanding fundamental knowledge in molecular pharmacology and cellular biology.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Pladienolide B | 445493-23-2 | sc-391691 sc-391691B sc-391691A sc-391691C sc-391691D sc-391691E | 0.5 mg 10 mg 20 mg 50 mg 100 mg 5 mg | $290.00 $5572.00 $10815.00 $25000.00 $65000.00 $2781.00 | 63 | |
This compound is known to target the splicing factor SF3b and could potentially disrupt the assembly or function of the spliceosome, thereby affecting PRPF31 activity. | ||||||
Isoginkgetin | 548-19-6 | sc-507430 | 5 mg | $225.00 | ||
Isoginkgetin is a biflavonoid that has been shown to inhibit splicing in vitro, which could indirectly affect the function of proteins like PRPF31. | ||||||
Madrasin | 374913-63-0 | sc-507563 | 100 mg | $750.00 | ||
Madrasin is a small molecule that specifically inhibits the splicing factor SPF45, potentially altering splicing activity where PRPF31 is involved. | ||||||
Chlorhexidine | 55-56-1 | sc-252568 | 1 g | $101.00 | 3 | |
Chlorhexidine has been shown to have some inhibitory effect on RNA polymerase, which could reduce overall mRNA synthesis including that of PRPF31. | ||||||
Spliceostatin A | 391611-36-2 | sc-507481 | 1 mg | $1800.00 | ||
Spliceostatin A is a potent inhibitor of the spliceosome, affecting its function and potentially altering the splicing activity of PRPF31. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $73.00 $238.00 $717.00 $2522.00 $21420.00 | 53 | |
It intercalates into DNA, preventing RNA polymerase from progressing, thus reducing transcription of many genes, potentially including PRPF31. | ||||||
DRB | 53-85-0 | sc-200581 sc-200581A sc-200581B sc-200581C | 10 mg 50 mg 100 mg 250 mg | $42.00 $185.00 $310.00 $650.00 | 6 | |
This compound inhibits RNA polymerase II, which could reduce transcription of many genes, potentially impacting the expression of PRPF31. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $260.00 $1029.00 | 26 | |
α-Amanitin is a potent inhibitor of RNA polymerase II, leading to decreased mRNA synthesis, which could affect PRPF31 transcription. | ||||||